Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.

Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. www.ncbi.nlm.nih.gov 2016年5月 Lancet Inf Dis に報告された、オランダ15施設による重症患者に対してプロカルを用いて抗菌薬投与期間を検討…